Sezgin, Y. Et Al. 2025. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer. Scientific Reports , vol.15, no.1 .

Sezgin, Y., Karhan, O., Aldemir, M. N., Ürün, M., Erçek, B. M., Urakcı, Z., ... Arvas, H.(2025). Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer. Scientific Reports , vol.15, no.1.

Sezgin, Yasin Et Al. "Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer," Scientific Reports , vol.15, no.1, 2025

Sezgin, Yasin Et Al. "Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer." Scientific Reports , vol.15, no.1, 2025

Sezgin, Y. Et Al. (2025) . "Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer." Scientific Reports , vol.15, no.1.

@article{article, author={Yasin Sezgin Et Al. }, title={Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer}, journal={Scientific Reports}, year=2025}